Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
ESC Heart Failure|October 7, 2016
Biological variation of the cardiac index in patients with stable chronic heart failure: inert gas rebreathing compared with impedance cardiographyTobias Täger, Hanna Fröhlich, Jennifer Franke, et al.
BMJ Open|July 30, 2018
Volume-outcome relationship in transcatheter aortic valve implantations in Germany 2008-2014: a secondary data analysis of electronic health recordsKlaus Kaier, Vera Oettinger, Holger Reinecke, et al.
ESC Heart Failure|July 31, 2018
Haemodynamic effects of percutaneous mitral valve edge-to-edge repair in patients with end-stage heart failure awaiting heart transplantationNicolas A Geis, Sven T Pleger, Raffi Bekeredjian, et al.
BMC Nephrology|May 16, 2020
Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patientsLeonie Grossekettler, Bastian Schmack, Carsten Brockmann, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 7, 2014
Gender aspects in clinical presentation and prognostication of chronic heart failure according to NT-proBNP and the Heart Failure Survival ScoreJennifer Franke, Andreas Lindmark, Matthias Hochadel, et al.
Plos One|June 12, 2020
The role of diabetes in cardiomyopathies of different etiologies-Characteristics and 1-year follow-up results of the EVITA-HF registryChristine Meindl, Matthias Hochadel, Lutz Frankenstein, et al.
Drug Design, Development and Therapy|March 12, 2015
Advantageous effects of immunosuppression with tacrolimus in comparison with cyclosporine A regarding renal function in patients after heart transplantationMatthias Helmschrott, Rasmus Rivinius, Arjang Ruhparwar, et al.
Heart Failure Reviews|August 1, 2019
Relative Efficacy of Spironolactone, Eplerenone, and cAnRenone in patients with Chronic Heart failure (RESEARCH): a systematic review and network meta-analysis of randomized controlled trialsLutz Frankenstein, Svenja Seide, Tobias Täger, et al.
Transplantation|November 19, 2009
Heart rate reduction for 12 months with ivabradine reduces left ventricular mass in cardiac allograft recipientsAndreas O Doesch, Kerstin Ammon, Mathias Konstandin, et al.
Journal of Cardiac Failure|August 1, 2017
Hemodynamic Determinants of the Biologic Variation of N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Stable Systolic Chronic Heart FailureTobias Täger, Ann-Kathrin Wiedergruen, Hanna Fröhlich, et al.
Pageof 12